Related Experiment Video
Updated: Aug 13, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Plasma homovanillic acid concentrations in catatonia
G Northoff1, L Demisch, J Wenke
1Department of Psychiatry, University of Frankfurt, Germany.
Biological Psychiatry
|March 15, 1996
Summary
Catatonic patients exhibit elevated plasma homovanillic acid (HVA) levels, a dopamine metabolite, compared to healthy individuals. This suggests altered dopaminergic function may underlie catatonia.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Catatonia is a complex psychomotor syndrome.
- Dopamine pathways are implicated in various psychiatric disorders.
- Homovanillic acid (HVA) is a key dopamine metabolite.
Purpose of the Study:
- To investigate plasma HVA levels in catatonic patients.
- To compare HVA levels between catatonic patients and healthy controls.
- To explore the relationship between HVA levels and neuroleptic treatment in catatonia.
Main Methods:
- Prospective study design.
- Diagnosis of catatonic syndrome using established criteria.
- Measurement of plasma HVA levels before initial medication in 37 catatonic patients and 17 controls.
Main Results:
- Catatonic patients showed significantly increased plasma HVA levels (140.9 +/- 53.6 pmol/mliter) compared to controls (80.1 +/- 40.1 pmol/mliter).
- Untreated catatonic patients (n=21) had significantly higher HVA than controls (p=0.0416).
- Neuroleptic-treated catatonics (n=16) did not differ significantly from controls.
Conclusions:
- Elevated plasma HVA in catatonia suggests altered mesolimbic, mesocortical, or nigrostriatal dopaminergic function.
- Findings support the hypothesis of dopaminergic dysregulation in catatonia, similar to schizophrenia.
- Further research is needed to elucidate the specific dopaminergic pathways involved.
